Louisiana biotech Therapeutic Neuromodulation Systems files Form D for equity offering
The Metairie-based company reported $969,500 sold toward a $5 million exempt offering, with 33 total investors as of the September 11, 2026 filing.
Therapeutic Neuromodulation Systems LLC, a limited liability company organized in Louisiana, filed a Form D notice of exempt securities offering with the Securities and Exchange Commission, signed September 11, 2026. The company is registered as a corporation type of Limited Liability Company, organized in Louisiana more than five years ago.1 Its principal place of business is listed at 4405 N I-10 Service W, Suite 100, in Metairie, Louisiana.1
The filing identifies Arnold Joseph Rougee of New Orleans, Louisiana, as an executive officer and manager of the company.1 The issuer classified its industry group under Health Care, specifically Biotechnology.1
According to the filing, the offering is a new notice with a date of first sale of October 15, 2017.1 The type of securities offered is equity.1 The company claimed exemption under Rule 506(b).1
On offering size, the total offering amount is $5,000,000, with $969,500 already sold and $4,030,500 remaining to be sold.1 The minimum investment accepted from any outside investor is $5,000.1
Regarding investors, the filing indicates six non-accredited investors have already invested in the offering, out of a total of 33 investors who have invested to date.1
On compensation and expenses, the filing reports $0 in sales commissions and $0 in finders' fees.1 For use of proceeds tied to payments to executive officers, directors, or promoters named in the filing, the company listed an estimated $350,000.1
The issuer indicated it does not intend the offering to last more than one year.1 The offering is not being made in connection with a business combination transaction such as a merger or acquisition.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.